(19)
(11) EP 4 359 054 A1

(12)

(43) Date of publication:
01.05.2024 Bulletin 2024/18

(21) Application number: 22829302.3

(22) Date of filing: 23.06.2022
(51) International Patent Classification (IPC): 
A61M 27/00(2006.01)
(52) Cooperative Patent Classification (CPC):
A61M 27/006
(86) International application number:
PCT/US2022/034706
(87) International publication number:
WO 2022/271938 (29.12.2022 Gazette 2022/52)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 23.06.2021 US 202163214239 P

(71) Applicant: Enclear Therapies, Inc.
Newburyport MA 01950 (US)

(72) Inventors:
  • RICCARDI, Gianna
    Berwick, ME 03908 (US)
  • SIOPES, William, X., Jr.
    Lowell, MA 01852 (US)
  • GLICKMAN, Marcie
    Salem, MA 01970 (US)
  • DEPASQUA, Anthony
    Newburyport, MA 01950 (US)
  • KALISH, Kevin
    Newburyport, MA 01950 (US)
  • VOSE, Joshua, G.
    Seattle, WA 98109 (US)
  • PATEL, Rajan
    Somerville, MA 02145 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) METHOD OF REGULATING GENE EXPRESSION